tacit bio innovation limited Company Information
Company Number
05700997
Next Accounts
Nov 2025
Shareholders
anthony john bartlett
sarah louise bartlett
Group Structure
View All
Industry
Other business support service activities n.e.c.
Registered Address
bennett corner house, 33 coleshill street, sutton coldfield, west midlands, B72 1SD
Website
www.tacitbio.comtacit bio innovation limited Estimated Valuation
Pomanda estimates the enterprise value of TACIT BIO INNOVATION LIMITED at £95.2k based on a Turnover of £236.3k and 0.4x industry multiple (adjusted for size and gross margin).
tacit bio innovation limited Estimated Valuation
Pomanda estimates the enterprise value of TACIT BIO INNOVATION LIMITED at £0 based on an EBITDA of £-63.6k and a 2.9x industry multiple (adjusted for size and gross margin).
tacit bio innovation limited Estimated Valuation
Pomanda estimates the enterprise value of TACIT BIO INNOVATION LIMITED at £541 based on Net Assets of £236 and 2.3x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Tacit Bio Innovation Limited Overview
Tacit Bio Innovation Limited is a live company located in sutton coldfield, B72 1SD with a Companies House number of 05700997. It operates in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in February 2006, it's largest shareholder is anthony john bartlett with a 60% stake. Tacit Bio Innovation Limited is a established, micro sized company, Pomanda has estimated its turnover at £236.3k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Tacit Bio Innovation Limited Health Check
Pomanda's financial health check has awarded Tacit Bio Innovation Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 8 areas for improvement. Company Health Check FAQs


1 Strong

1 Regular

8 Weak

Size
annual sales of £236.3k, make it smaller than the average company (£4m)
- Tacit Bio Innovation Limited
£4m - Industry AVG

Growth
3 year (CAGR) sales growth of -30%, show it is growing at a slower rate (8.1%)
- Tacit Bio Innovation Limited
8.1% - Industry AVG

Production
with a gross margin of 17%, this company has a higher cost of product (38.2%)
- Tacit Bio Innovation Limited
38.2% - Industry AVG

Profitability
an operating margin of -26.9% make it less profitable than the average company (5.7%)
- Tacit Bio Innovation Limited
5.7% - Industry AVG

Employees
with 2 employees, this is below the industry average (24)
2 - Tacit Bio Innovation Limited
24 - Industry AVG

Pay Structure
on an average salary of £49.7k, the company has an equivalent pay structure (£49.7k)
- Tacit Bio Innovation Limited
£49.7k - Industry AVG

Efficiency
resulting in sales per employee of £118.1k, this is less efficient (£154.3k)
- Tacit Bio Innovation Limited
£154.3k - Industry AVG

Debtor Days
it gets paid by customers after 103 days, this is later than average (39 days)
- Tacit Bio Innovation Limited
39 days - Industry AVG

Creditor Days
its suppliers are paid after 131 days, this is slower than average (33 days)
- Tacit Bio Innovation Limited
33 days - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- Tacit Bio Innovation Limited
- - Industry AVG

Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Tacit Bio Innovation Limited
- - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 99.7%, this is a higher level of debt than the average (60.6%)
99.7% - Tacit Bio Innovation Limited
60.6% - Industry AVG
TACIT BIO INNOVATION LIMITED financials

Tacit Bio Innovation Limited's latest turnover from February 2024 is estimated at £236.3 thousand and the company has net assets of £236. According to their latest financial statements, Tacit Bio Innovation Limited has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | Feb 2013 | Feb 2012 | Feb 2011 | Feb 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | |||||||||||||||
Tax | |||||||||||||||
Profit After Tax | |||||||||||||||
Dividends Paid | |||||||||||||||
Retained Profit | |||||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 2 | |||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | Feb 2013 | Feb 2012 | Feb 2011 | Feb 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 3,967 | 541 | 2,296 | 3,185 | 5,068 | 1,651 | 73 | 207 | 589 | 1,448 | 2,039 | 1,536 | 2,376 | 3,905 | 10,708 |
Intangible Assets | |||||||||||||||
Investments & Other | 20,043 | 20,043 | 20,043 | 20,043 | 20,043 | 20,043 | |||||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 3,967 | 541 | 2,296 | 3,185 | 5,068 | 1,651 | 73 | 207 | 589 | 21,491 | 22,082 | 21,579 | 22,419 | 23,948 | 30,751 |
Stock & work in progress | 17,093 | ||||||||||||||
Trade Debtors | 66,965 | 140,096 | 325,878 | 274,703 | 260,097 | 302,426 | 326,470 | 11,663 | 29,868 | 1,558 | 30,335 | 19,255 | 13,316 | 15,375 | |
Group Debtors | |||||||||||||||
Misc Debtors | 1,027 | 906 | |||||||||||||
Cash | 398,039 | 324,189 | 260,697 | 200,533 | 148,057 | 222,233 | 235,401 | 202,326 | |||||||
misc current assets | 112 | ||||||||||||||
total current assets | 66,965 | 140,096 | 325,878 | 274,703 | 260,097 | 302,426 | 326,582 | 410,729 | 342,188 | 290,565 | 202,091 | 178,392 | 241,488 | 248,717 | 217,701 |
total assets | 70,932 | 140,637 | 328,174 | 277,888 | 265,165 | 304,077 | 326,655 | 410,936 | 342,777 | 312,056 | 224,173 | 199,971 | 263,907 | 272,665 | 248,452 |
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 70,696 | 76,768 | 242,780 | 154,968 | 79,876 | 46,723 | 48,839 | 630 | 368 | 110,429 | 86,727 | 70,759 | 134,660 | 144,511 | 130,808 |
Group/Directors Accounts | |||||||||||||||
other short term finances | |||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 116,244 | 102,761 | |||||||||||||
total current liabilities | 70,696 | 76,768 | 242,780 | 154,968 | 79,876 | 46,723 | 48,839 | 116,874 | 103,129 | 110,429 | 86,727 | 70,759 | 134,660 | 144,511 | 130,808 |
loans | |||||||||||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | |||||||||||||||
provisions | 1 | 94 | 229 | 296 | 171 | 317 | 672 | 1,189 | |||||||
total long term liabilities | 1 | 94 | 229 | 296 | 171 | 317 | 672 | 1,189 | |||||||
total liabilities | 70,696 | 76,768 | 242,780 | 154,968 | 79,876 | 46,723 | 48,839 | 116,875 | 103,223 | 110,658 | 87,023 | 70,930 | 134,977 | 145,183 | 131,997 |
net assets | 236 | 63,869 | 85,394 | 122,920 | 185,289 | 257,354 | 277,816 | 294,061 | 239,554 | 201,398 | 137,150 | 129,041 | 128,930 | 127,482 | 116,455 |
total shareholders funds | 236 | 63,869 | 85,394 | 122,920 | 185,289 | 257,354 | 277,816 | 294,061 | 239,554 | 201,398 | 137,150 | 129,041 | 128,930 | 127,482 | 116,455 |
Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | Feb 2013 | Feb 2012 | Feb 2011 | Feb 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 460 | 727 | 1,016 | 1,303 | 1,300 | 2,777 | 4,168 | 7,664 | |||||||
Amortisation | |||||||||||||||
Tax | |||||||||||||||
Stock | -17,093 | 17,093 | |||||||||||||
Debtors | -73,131 | -185,782 | 51,175 | 14,606 | -42,329 | -24,044 | 313,780 | 11,784 | -28,962 | 28,310 | -28,777 | 11,080 | 5,939 | -2,059 | 15,375 |
Creditors | -6,072 | -166,012 | 87,812 | 75,092 | 33,153 | -2,116 | 48,209 | 262 | -110,061 | 23,702 | 15,968 | -63,901 | -9,851 | 13,703 | 130,808 |
Accruals and Deferred Income | -116,244 | 13,483 | 102,761 | ||||||||||||
Deferred Taxes & Provisions | -1 | -93 | -135 | -67 | 125 | -146 | -355 | -517 | 1,189 | ||||||
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | -20,043 | 20,043 | |||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | |||||||||||||||
Other Short Term Loans | |||||||||||||||
Long term loans | |||||||||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | |||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | -398,039 | 73,850 | 63,492 | 60,164 | 52,476 | -74,176 | -13,168 | 33,075 | 202,326 | ||||||
overdraft | |||||||||||||||
change in cash | -398,039 | 73,850 | 63,492 | 60,164 | 52,476 | -74,176 | -13,168 | 33,075 | 202,326 |
tacit bio innovation limited Credit Report and Business Information
Tacit Bio Innovation Limited Competitor Analysis

Perform a competitor analysis for tacit bio innovation limited by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other micro companies, companies in B72 area or any other competitors across 12 key performance metrics.
tacit bio innovation limited Ownership
TACIT BIO INNOVATION LIMITED group structure
Tacit Bio Innovation Limited has no subsidiary companies.
Ultimate parent company
TACIT BIO INNOVATION LIMITED
05700997
tacit bio innovation limited directors
Tacit Bio Innovation Limited currently has 2 directors. The longest serving directors include Mrs Sarah Bartlett (Apr 2006) and Mr Anthony Bartlett (Apr 2006).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mrs Sarah Bartlett | 56 years | Apr 2006 | - | Director | |
Mr Anthony Bartlett | 63 years | Apr 2006 | - | Director |
P&L
February 2024turnover
236.3k
-34%
operating profit
-63.6k
0%
gross margin
17%
-3.22%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
February 2024net assets
236
-1%
total assets
70.9k
-0.5%
cash
0
0%
net assets
Total assets minus all liabilities
tacit bio innovation limited company details
company number
05700997
Type
Private limited with Share Capital
industry
82990 - Other business support service activities n.e.c.
incorporation date
February 2006
age
19
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
February 2024
previous names
touchdown biomarketing limited (December 2011)
sk 111 limited (April 2006)
accountant
-
auditor
-
address
bennett corner house, 33 coleshill street, sutton coldfield, west midlands, B72 1SD
Bank
-
Legal Advisor
-
tacit bio innovation limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to tacit bio innovation limited.
tacit bio innovation limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for TACIT BIO INNOVATION LIMITED. This can take several minutes, an email will notify you when this has completed.
tacit bio innovation limited Companies House Filings - See Documents
date | description | view/download |
---|